Metronidazole and Cirrhosis alcoholic - a phase IV clinical study of FDA data


Cirrhosis alcoholic is found among people who take Metronidazole, especially for people who are female, 50-59 old, have been taking the drug for < 1 month.

The phase IV clinical study analyzes which people take Metronidazole and have Cirrhosis alcoholic. It is created by eHealthMe based on reports of 43,868 people who have side effects when taking Metronidazole from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.

On Jul, 15, 2022

43,868 people reported to have side effects when taking Metronidazole.
Among them, 8 people (0.02%) have Cirrhosis alcoholic.

What is Metronidazole?

Metronidazole has active ingredients of metronidazole. It is often used in vaginitis bacterial. eHealthMe is studying from 45,199 Metronidazole users for its effectiveness, alternative drugs and more.

What is Cirrhosis alcoholic?

Cirrhosis alcoholic (chronic disease of the liver marked by degeneration of cells, inflammation, and fibrous thickening of tissue caused by alcoholism) is found to be associated with 360 drugs and 159 conditions by eHealthMe.

Number of Metronidazole and Cirrhosis alcoholic reports submitted per year:

Could Metronidazole cause Cirrhosis alcoholic?

Time on Metronidazole when people have Cirrhosis alcoholic *:

  • < 1 month: 100 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Cirrhosis alcoholic when taking Metronidazole *:

  • female: 75 %
  • male: 25 %

Age of people who have Cirrhosis alcoholic when taking Metronidazole *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 37.5 %
  • 50-59: 37.5 %
  • 60+: 25.0 %

Common drugs people take besides Metronidazole *:

  1. Vancomycin: 4 people, 50.00%
  2. Metoclopramide: 4 people, 50.00%
  3. Zinc Sulfate: 3 people, 37.50%
  4. Cefazolin: 3 people, 37.50%
  5. Magnesium Sulfate: 3 people, 37.50%
  6. Nexium: 3 people, 37.50%
  7. Colace: 3 people, 37.50%
  8. Phytonadione: 3 people, 37.50%
  9. Cimetidine: 3 people, 37.50%
  10. Reglan: 3 people, 37.50%

Common side effects people have besides Cirrhosis alcoholic *:

  1. Septic Shock (shock due to blood infection): 3 people, 37.50%
  2. Unresponsive To Stimuli: 3 people, 37.50%
  3. Hepatomegaly (abnormal enlargement of the liver): 3 people, 37.50%
  4. Speech Impairment (Adult) (inability to speak (adult)): 3 people, 37.50%
  5. Hepatitis Alcoholic (inflammation of the liver due to alcohol): 3 people, 37.50%
  6. Erythema Multiforme (a type of hypersensitivity reaction): 3 people, 37.50%
  7. Chronic Hepatic Failure (long lasting liver failure): 3 people, 37.50%
  8. Tonsil Cancer: 2 people, 25.00%
  9. Delirium Tremens (a psychotic condition typical of withdrawal in chronic alcoholics): 1 person, 12.50%
  10. Malnutrition (condition that results from eating a diet in which certain nutrients are lacking): 1 person, 12.50%

Common conditions people have *:

  1. Fluid Retention (an abnormal accumulation of fluid in the blood): 1 person, 12.50%
  2. Clostridium Colitis (inflammation of colon by clostridium difficile bacteria infection): 1 person, 12.50%

* Approximation only. Some reports may have incomplete information.

Do you take Metronidazole and have Cirrhosis alcoholic?

Check whether Cirrhosis alcoholic is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Alternative drugs to, pros and cons of Metronidazole:

Cirrhosis alcoholic treatments and more:

COVID vaccines that are related to Cirrhosis alcoholic:

How severe was Cirrhosis alcoholic and when was it recovered:

Expand to all the drugs that have ingredients of metronidazole:

All the drugs that are associated with Cirrhosis alcoholic:

All the conditions that are associated with Cirrhosis alcoholic:

How the study uses the data?

The study uses data from the FDA. It is based on metronidazole (the active ingredients of Metronidazole) and Metronidazole (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: